Cargando…

A systematic review and meta-analysis: Association between MGMT hypermethylation and the clinicopathological characteristics of non-small-cell lung carcinoma

The relationship between O-6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and clinicopathological characteristics of non-small-cell lung carcinoma (NSCLC) has remained controversial and unclear. Therefore, in this study we have undertaken a systematic review and meta-analysis of r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Lin, Wang, Yong, Liu, Fen, Xu, Liyao, Peng, Feifei, Zhao, Ning, Fu, Biqi, Zhu, Zijie, Shi, Yu, Liu, Jiansheng, Wu, Renrui, Wang, Chen, Yao, Shengmin, Li, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780517/ https://www.ncbi.nlm.nih.gov/pubmed/29362385 http://dx.doi.org/10.1038/s41598-018-19949-z

Ejemplares similares

Alu hypomethylation and MGMT hypermethylation in serum as biomarkers of glioma
por: Gong, Mingjie, et al.
Publicado: (2017)

Efficacy and tolerability of granulocyte colony-stimulating factors in cancer patients after chemotherapy: A systematic review and Bayesian network meta-analysis
por: Wang, Yong, et al.
Publicado: (2019)

Clinical strategies to manage adult glioblastoma patients without MGMT hypermethylation
por: Liu, Delin, et al.
Publicado: (2022)

Concurrent hypermethylation of DNMT1, MGMT and EGFR genes in progression of gliomas
por: Gömöri, Éva, et al.
Publicado: (2012)

GEN-06 CLINICAL COURSE AFTER TUMOR RECURRENCE OF MGMT HYPERMETHYLATED GLIOBLASTOMA
por: Adachi, Junichi, et al.
Publicado: (2019)

Combination of rapamycin and SAHA enhanced radiosensitization by inducing autophagy and acetylation in NSCLC
por: Wang, Yong, et al.
Publicado: (2021)

The Prognostic Value of Pyrosequencing-Detected MGMT Promoter Hypermethylation in Newly Diagnosed Patients with Glioblastoma
por: Villani, Veronica, et al.
Publicado: (2015)

Dual MGMT inactivation by promoter hypermethylation and loss of the long arm of chromosome 10 in glioblastoma
por: Richard, Sophie, et al.
Publicado: (2020)

The Correlation of MGMT Promoter Methylation and Clinicopathological Features in Gastric Cancer: A Systematic Review and Meta-Analysis
por: Ding, Yong, et al.
Publicado: (2016)

High Specificity of Quantitative Methylation-Specific PCR Analysis for MGMT Promoter Hypermethylation Detection in Gliomas
por: Parrella, Paola, et al.
Publicado: (2009)

Associations of MGMT promoter hypermethylation with squamous intraepithelial lesion and cervical carcinoma: A meta-analysis
por: Huang, Jin, et al.
Publicado: (2019)

Hypermethylation status of DAPK, MGMT and RUNX3 in HPV negative oral and oropharyngeal squamous cell carcinoma
por: dos Reis, Raquel Silva, et al.
Publicado: (2020)

Molecular and Clinicopathological Characterization of a Prognostic Immune Gene Signature Associated With MGMT Methylation in Glioblastoma
por: Zhao, Liang, et al.
Publicado: (2021)

Clinicopathological and prognostic significance of CDH1 hypermethylation in hepatocellular carcinoma: a meta-analysis
por: Wu, Xiaoyu, et al.
Publicado: (2019)

The clinicopathological significance of FHIT hypermethylation in non-small cell lung cancer, a meta-analysis and literature review
por: Yan, Wei, et al.
Publicado: (2016)

MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation
por: Groenendijk, Floris H., et al.
Publicado: (2010)

Promoter hypermethylation of MGMT gene may contribute to the pathogenesis of gastric cancer: A PRISMA-compliant meta-analysis
por: Zhang, Zongxin, et al.
Publicado: (2017)

Associations among smoking, MGMT hypermethylation, TP53-mutations, and relapse in head and neck squamous cell carcinoma
por: Matsuda, Shinichi, et al.
Publicado: (2020)

Clinicopathological significance of p15 promoter hypermethylation in multiple myeloma: a meta-analysis
por: Wei, Bing, et al.
Publicado: (2016)

Frequent MGMT (0(6)-methylguanine-DNA methyltransferase) hypermethylation in long-term survivors of glioblastoma: a single institution experience
por: Baur, Martina, et al.
Publicado: (2010)

MGMT promoter hypermethylation and K-RAS, PTEN and TP53 mutations in tamoxifen-exposed and non-exposed endometrial cancer cases
por: Nagy, E, et al.
Publicado: (2014)

A innovative prognostic symbol based on neutrophil extracellular traps (NETs)-related lncRNA signature in non-small-cell lung cancer
por: Fang, Chen, et al.
Publicado: (2021)

The clinicopathological significance and ethnic difference of FHIT hypermethylation in non-small-cell lung carcinoma: a meta-analysis and literature review
por: Wu, Xiaoyu, et al.
Publicado: (2016)

Clinicopathological Significance of CDKN2A Promoter Hypermethylation Frequency with Pancreatic Cancer
por: Tang, Bo, et al.
Publicado: (2015)

The clinicopathological significance of hMLH1 hypermethylation in non-small-cell lung cancer: a meta-analysis and literature review
por: Han, Yi, et al.
Publicado: (2016)

Promoter hypermethylation of MGMT, CDH1, RAR-β and SYK tumour suppressor genes in granulosa cell tumours (GCTs) of ovarian origin
por: Dhillon, V S, et al.
Publicado: (2004)

Association between MGMT Enhancer Methylation and MGMT Promoter Methylation, MGMT Protein Expression, and Overall Survival in Glioblastoma
por: Zappe, Katja, et al.
Publicado: (2023)

Clinicopathological significance of the p16 hypermethylation in multiple myeloma, a systematic review and meta-analysis
por: Yu, Huiqing, et al.
Publicado: (2017)

Neutrophil Extracellular Traps (NETs) Promote Non-Small Cell Lung Cancer Metastasis by Suppressing lncRNA MIR503HG to Activate the NF-κB/NLRP3 Inflammasome Pathway
por: Wang, Yong, et al.
Publicado: (2022)

Sex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastoma
por: Schiffgens, Salveena, et al.
Publicado: (2016)

Clinicopathological characteristics and survival of spinal cord astrocytomas
por: Zhang, Yao‐Wu, et al.
Publicado: (2020)

Associations of P16(INK4a) promoter hypermethylation with squamous intra-epithelial lesion, cervical cancer and their clinicopathological features: a meta-analysis
por: Han, Ya-di, et al.
Publicado: (2016)

Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide
por: van Nifterik, K A, et al.
Publicado: (2010)

Clinicopathological significance of WIF1 hypermethylation in NSCLC, a meta-analysis and literature review
por: Guo, Hao, et al.
Publicado: (2016)

Comprehensive Analysis of MGMT Promoter Methylation: Correlation with MGMT Expression and Clinical Response in GBM
por: Shah, Nameeta, et al.
Publicado: (2011)

Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma
por: Oliver, Jaime Antonio, et al.
Publicado: (2014)

A ”Clickable” Probe for Active MGMT in Glioblastoma Demonstrates Two Discrete Populations of MGMT
por: Raghavan, Sudhir, et al.
Publicado: (2020)

Clinicopathological Characteristics and Survival of Small Cell Carcinoma of the Salivary Gland: a Population-Based Study
por: Bai, Jinbo, et al.
Publicado: (2019)

A retrospective analysis of the clinicopathological and molecular characteristics of pulmonary blastoma
por: Zhao, Yuan-Yuan, et al.
Publicado: (2016)

Up-regulation of miR-370-3p restores glioblastoma multiforme sensitivity to temozolomide by influencing MGMT expression
por: Gao, Yong-tao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7pgffktrjiivv48i2q3877qs47